Comparison of diclofenac Transdermal patch with diclofenac rectal Suppository in management of postoperative pain

Comparative evaluation of efficacy of diclofenac Transdermal patch versus diclofenac rectal Suppository for management of post operative pain following open cholecystectomy:A Randomised Clinical Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032257

Enrollment

Registered

2021-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K811- Chronic cholecystitis

Interventions

Intervention1: Diclofenac Transdermal patch: 100mg diclofenac Transdermal patch to be used 12 hourly for 48 hours, patch will be attached on inner aspect of left arm. Intervention2: Diclofenac Rectal

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed as case of chronic cholecystitis

Exclusion criteria

Exclusion criteria: Age less than 18 years and more than 65 years,Acute cholecystitis, renal and hepatic disorder, substance abuse, pregnant and lactating women, allergic to drugs used in trial, patients of cardiovascular disorders, patients of peptic ulcer, Gastritis, copd , asthma

Design outcomes

Primary

Measure	Time frame
Analysis of visual analogue scoreTimepoint: at recovery time, at 3,6,12,24 hrs respectively	—

Secondary

Measure	Time frame
Analysis of any adverse eventsTimepoint: At recovery time, 3,6,12,24 hours respectively	—

Countries

India

Contacts

Public ContactDr shivangna Singh

FH Medical College and Hospital

vivu25gtm@gmail.com09760241909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026